Magnet.me - Het slimme netwerk waar studenten en professionals hun stage of baan vinden.
Het slimme netwerk waar studenten en professionals hun stage of baan vinden.
Bouw aan je carrière op Magnet.me
Maak een profiel aan en ontvang slimme aanbevelingen op basis van je gelikete vacatures.
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients’ worldwide.
The Sr. Marketing Manager, EMEA will be responsible for developing, in collaboration with the Sr. Director Professional Education and Marketing the commercial and go-to-market strategy for the EMEA business at AtriCure. The person in this role is accountable for working with stakeholders across the business, including Sales, Operations, Finance, Quality Systems and Regulatory, as well as managing people in the EMEA Marketing function.
💼 What You’ll Do
🎯 What We’re Looking For
🌱 Why Join Us?
At AtriCure, we’re committed to innovation, collaboration, and improving lives. You’ll be part of a purpose-driven team making a global impact in cardiac care. We offer a dynamic work environment, opportunities for growth, and the chance to shape the future of our EMEA business.
In Addition, AtriCure Also Provides:
Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted to date.
Bekijk ons aanbod:
Resources:
Change language to: English
Deze pagina is geoptimaliseerd voor mensen uit Nederland. Bekijk de versie geoptimaliseerd voor mensen uit het Verenigd Koninkrijk.